Latest News
Search News
BCI researcher receives prestigious MRC grant to investigate how HPV infection develops into cancer
27th May 2022
Dr Sarah McClelland from BCI is part of a collaborative project that has secured £1.2 million in funding from the Medical Research Council to investigate the mechanisms leading to cancer development in cells infected with human papillomavirus.
Read more
In conversation with Professor Marco Gerlinger
20th May 2022
This International Clinical Trials Day, we spoke with Professor Marco Gerlinger. Professor Gerlinger and his team’s laboratory research focuses on understanding and overcoming drug resistance in bowel and gastro-oesophageal cancers, and identifying new and more effective ways to treat these cancers using immunotherapies and combination therapies.
Read more
£3.1 million for PROTECT trial
6th May 2022
Yorkshire Cancer Research has announced a £3.1 million grant for research led by Ranjit Manchanda to investigate the risks, benefits, and feasibility of introducing population-based genetic testing for ‘all’ women to find out if they are at high risk of cancer. Thousands of women living in Yorkshire and other parts of the UK will be offered tests as part of the PROTECT (Population based germline testing for early detection and cancer prevention) clinical trial.
Read more
Investigating new treatment targets for lymphoma, and beyond
5th May 2022
We spoke with Dr John Riches, Clinical Senior Lecturer in the Centre for Haemato-Oncology at Barts Cancer Institute, Queen Mary University of London, about his team’s recent publication, which describes a new potential treatment target for a subset of lymphomas.
Read more
Introducing Dr Diu Nguyen
29th April 2022
We would like to wish a very warm welcome to Dr Diu Nguyen who has recently joined the Barts Cancer Institute, Queen Mary University of London as a Lecturer and Group Leader. Dr Nguyen joins us from the Memorial Sloan Kettering Cancer Center in New York, USA, where she completed her postdoctoral training investigating the role of post-transcriptional regulation in normal and malignant cancer stem cells.
Read more
Study suggests simple blood test could help to monitor pancreatic cancer patients
28th April 2022
Researchers from Barts Cancer Institute at Queen Mary University of London have found it is possible to identify and track genetic variations in the tumours of patients with pancreatic cancer using a simple blood test.
Read more